Omeros Corporation (Nasdaq: OMER) today announced statistical sensitivity analysis results related to the primary endpoint ...

Omeros (OMER) announced statistical sensitivity analysis results related to the primary endpoint analysis for narsoplimab, Omeros’ monoclonal ...

Corporation (NASDAQ: OMER), a biotechnology company with a market capitalization of $515.75 million, today reported results ...

For instance, in atypical hemolytic uremic syndrome, complement factor H fails to perform its regulatory role in the complement system effectively, resulting in over-activation of the complement ...

While they’re generally safe for consumption, some individuals may suffer from negative effects like digestive problems, inflammation, and autoimmune reactions due to lectin intake. As a result ...

GOVERNOR MAURA HEALEY RECENTLY SIGNED IT INTO LAW AS THE PHYSICIAN PATHWAY ACT. A BUSY PRIMARY CARE DOCTOR TAKES CARE OF 1500 TO UP TO 2000 PATIENTS, SO JUST EVEN ONE PERSON GO INTO A COMMUNITY ...

After hours report provides a review of the day’s stock market and treasury market session performance with a recap of indices, sector, and industry performance, trends, as well as key news items that ...

Recipient T cells recognize donor antigens via two distinct pathways: the direct pathway (intact donor MHC ... and via direct complement-dependent, antibody-mediated cytotoxicity.